Molecular Pathology of Skin Carcinogenesis due to Arsenicalism from Coal-Burning

Archives of Environmental Health

Volumn 58, Issue 2, 2003, Pages 92-96

  Hu, Chang Jun ^a   Zhang, Ai Hua ^b   Huang, Hsiao Hsin ^c  

^a HUAIHUA MEDICAL COLLEGE   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c The 44th Hospital of PLA   (China)

Author keywords

Arsenicalism; Bcl 2 p rotein; Coal burning; Immunohistochemistry; P53 protein; Pcna; Skin disease

Indexed keywords

ARSENIC; COAL; CYCLINE; INORGANIC COMPOUND; MUTANT PROTEIN; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

AIR POLLUTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE CONTROL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN BIOPSY; SKIN CARCINOGENESIS; SKIN CARCINOMA; UPREGULATION;

EID: 0038638242     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.3200/AEOH.58.2.92-96     Document Type: Article

References (21)

1. Guo HR, Chen CJ, Greene HL. Arsenic in drinking water and cancers: a brief descriptive review of the Taiwan studies. In: Chappell WR, Abernathy CO, Cothem CR (Eds). Arsenic Exposure and Health. Northwood, U.K.: Science and Technology Letters. 1994; pp 129-38.
2. Carlson-Lynch H, Beak BD, Boardman PD. Arsenic risk assessment. Environ Health Perspect 1994; 102(4):354-56.
3. Chao SR. Investigation and current study on pollution of inorganic arsenic in China. Chin J Public Health (Taiwan) 1996; 15(Appl):6-10.
4. Zhou YS, Zhou DX. Investigation on chronic arsenicalism due to coal burning. Chin J Public Health 1994; 10(1):41.
5. Zhou DX, Zhou YS, Zhou C. Study on correlation between the total amounts of arsenic of villagers and their state of arsenicalism. Chin J Endemiol 1994: 13(4):215-17.
6. Liu DN, Lu XZ, Li BL, et al. Clinical analysis on 535 patients with arsenicalism from burning coal containing high arsenic. Chin J Intern Med 1992; 31(9):260-62.
7. Ling P, Liu M, Li DS, et al. Analysis of clinical symptoms and signs of arsenism caused by coal-burning pollution. Chin J Endemiol 2000; 19(2): 139-141.
8. Zhang AH, Huang XX, Luo P, et al. Influences of inorganic arsenic in patients with arsenicalism from coal-burning and correlative factors on development of the arsenicalism. Chin J Guiyang Med Coll 1999; 24(4):326-29.
9. Chai CY, Yen HT, et al. The inhibitory effect of UVB irradiation on the expression of P53 and Ki-67 proteins in arsenic-induced Bowens disease. J Cutan Pathol 1997; 24:8-13.
10. Shibate A, Ohneseit PF, Tsai YC, et al. Mutational spectrum in the P53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 1994; 15(6):1085-87.
11. Sim CS, Slater SD, Mckee PH. Mutant P53 protein is expressed in Bowen s disease. Am J Dermatol 1992; 14:195-99.
12. Tokata M, Matsui Y. Proliferating cell nuclear antigen (PCNA) and P53 protein expression in Bowen's disease. J Dermatol 1995; 21:947-52.
13. Bravo R, Frank R, Blundell PA, etal. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326:515-17.
14. Cohen SM. Ellwein LB. Cell proliferation in carcinogenesis. Science 1990; 249:1007-11.
15. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-62.
16. Hockenbery D, Nunez G, Mil liman C, et al. BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348(6299):334-36.
17. Reed JC. BCL-2 and the regulation of programmed cell death. J Cell Biol 1994; 124:1-6.
18. Vogelstein BA. Deadly inheritance. Nature 1990; 348(6303): 681-82.
19. Deb S, Jackson CT, Subler MA, et al. Modulation of cellular and viral promoters by mutant human P53 protein found in tumor cells. J Virol 1992; 66:6164-70.
20. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of P53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994; 86:681-87.
21. Harris CC, Hollstein M. Clinical implications of the P53 tumor-suppressor gene. N Engl J Med 1993; 329:1318-27.